Opioid Education Resources
In April 2011, FDA announced the elements of a Risk Evaluation and Mitigation Strategy (REMS) to ensure that the benefits of extended-release and long-acting (ER/LA) opioid analgesics outweigh the risks. The REMS supports national efforts to address the prescription drug abuse epidemic.
The Foundation is providing otolaryngology-head and neck physicians and surgeons with information regarding this REMS and access to REMS-compliant education programs that address this issue. If you wish to learn more and to participate in these programs please visit our new opioids page.
The Journal Otolaryngology—Head and Neck Surgery presents peer-reviewed articles and case reports on recent developments in treatment of the ear, nose, throat, and related structures of the head and neck. The journal also provides concise presentations of new instruments and medical devices, as well as articles describing the complications and side effects of new drugs.